Company intelligence / Profile preview

SJS Life Sciences

Bannockburn, Illinois, United States

Ownership: Private
Development stage: Other

Overview

SJS Life Sciences is a specialty pharmaceutical company focused on developing innovative therapies for pain management and central nervous system disorders. The company's primary mission is to address the opioid crisis by developing non-addictive or safer alternatives for chronic pain relief. SJS Life Sciences leverages its expertise in drug formulation and delivery to optimize existing compounds and explore new chemical entities. The firm aims to bridge the gap between early-stage research and commercialization through strategic partnerships and targeted clinical development.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on SJS Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SJS Life Sciences.

Explore the full profile